Mannkind (MNKD) Capital Expenditures (2010 - 2026)
Mannkind's (MNKD) quarterly Capital Expenditures came in at $267000.0 in Q1 2026, down 19.09% year-on-year from $330000.0 in Q1 2025, and up 229.61% on a QoQ basis from -$206000.0 in Q4 2025.
Mannkind (MNKD) Capital Expenditures (2010 - 2026) Analysis & Trends
Mannkind (MNKD) has 15 years of Capital Expenditures data on file, last reported at $267000.0 in Q1 2026.
- On a quarterly basis, Capital Expenditures fell 19.09% year-over-year to $267000.0 in Q1 2026; TTM through Mar 2026 was $556000.0, a 239.35% increase from a year earlier, with the FY2025 full-year figure at $619000.0, down 63.13% from the prior year.
- Capital Expenditures for Q1 2026 stood at $267000.0, up from -$206000.0 in the prior quarter.
- Over the last five years, Capital Expenditures for MNKD reached as high as $8.3 million in Q1 2023 and fell as low as -$6.5 million in Q2 2023.
- Historically, Capital Expenditures has averaged $326705.9 across 5 years, with a median of $267000.0 in 2026.
- On a YoY basis, Capital Expenditures climbed as much as 2069.97% in 2023 and fell as far as 1310.69% in 2023.
- Year by year, Capital Expenditures stood at -$135000.0 in 2022, then plunged by 491.85% to -$799000.0 in 2023, then jumped by 124.16% to $193000.0 in 2024, then tumbled by 206.74% to -$206000.0 in 2025, then jumped by 229.61% to $267000.0 in 2026.
- Per Business Quant data, the three most recent Capital Expenditures figures were $267000.0 in Q1 2026, -$206000.0 in Q4 2025, and -$622000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -8,939.03 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 43.25 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 133.40 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 230.60 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 786,000.00 |
| 10 | Mannkind | 1.20 Bn | 1.07 Bn | 82.66 Mn | 267,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 267,000.00 |
| Mar 31, 2026 | 267,000.00 |
| Dec 31, 2025 | -206,000.00 |
| Dec 31, 2025 | -206,000.00 |
| Sep 30, 2025 | -622,000.00 |
| Sep 30, 2025 | -622,000.00 |
| Jun 30, 2025 | 1.12 Mn |
| Jun 30, 2025 | 1.12 Mn |
| Mar 31, 2025 | 330,000.00 |
| Mar 31, 2025 | 330,000.00 |
| Dec 31, 2024 | 193,000.00 |
| Dec 31, 2024 | 193,000.00 |
| Sep 30, 2024 | 82,000.00 |
| Sep 30, 2024 | 82,000.00 |
| Jun 30, 2024 | -1.00 Mn |
| Jun 30, 2024 | -1.00 Mn |
| Mar 31, 2024 | 2.41 Mn |
| Mar 31, 2024 | 2.41 Mn |
| Dec 31, 2023 | -799,000.00 |
| Dec 31, 2023 | -799,000.00 |